<DOC>
	<DOCNO>NCT00240344</DOCNO>
	<brief_summary>The purpose study determine efficacy Crestor high risk patient switch high dos statin obtain new European Atherosclerosis Society ( EAS ) low-density lipoprotein cholesterol ( LDL-C ) guideline .</brief_summary>
	<brief_title>Study High Risk Patients Switched From Higher Doses Other Statins Crestor Percentage Patients Reaching New LDL-C Target Goal</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>High risk patient High dos statin LDLC know , start Crestor 10 mg Permission use patient data AstraZeneca ( AZ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>High risk patient</keyword>
	<keyword>Crestor</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>LDL cholesterol</keyword>
	<keyword>observational</keyword>
</DOC>